2009
DOI: 10.1111/j.1365-2265.2009.03572.x
|View full text |Cite
|
Sign up to set email alerts
|

Congenital hypopituitarism: clinical, molecular and neuroradiological correlates

Abstract: Our data suggest that individuals presenting with ONH are at high risk for neuroradiologic and endocrine abnormalities. The neuroradiologic features are predictive not only of the presence, but also of the type, of hypopituitarism. The association of midline abnormalities with hypopituitarism in this cohort suggests a common developmental origin for these features, the aetiology of which remains unidentified in the majority of cases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
50
2
4

Year Published

2009
2009
2019
2019

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 87 publications
(63 citation statements)
references
References 34 publications
7
50
2
4
Order By: Relevance
“…Our data cannot be compared with those described in the literature (4,23,35) as the frequency of CDI in SOD has been reported in as high as 6-38% of patients with SOD (Table 3). In particular, among previously described patients, 38% of 24 patients with SOD showed CDI, although a water deprivation test was performed in only 12 of the 24 subjects (23).…”
Section: Discussioncontrasting
confidence: 55%
See 3 more Smart Citations
“…Our data cannot be compared with those described in the literature (4,23,35) as the frequency of CDI in SOD has been reported in as high as 6-38% of patients with SOD (Table 3). In particular, among previously described patients, 38% of 24 patients with SOD showed CDI, although a water deprivation test was performed in only 12 of the 24 subjects (23).…”
Section: Discussioncontrasting
confidence: 55%
“…All patients were being treated with recombinant human GH at conventional dosages and subjects with MPHD were receiving conventional therapy for pituitary defects with good adherence as revealed by normal serum concentration of FT 4 and cortisol: L-T 4 75-200 mg/day, hydrocortisone 15-20 mg/day in two to three separate doses, testosterone enanthate 150-250 mg i.m. every 2 or 3 weeks for male subjects, and ethinyl estradiol or transdermal 17b-estradiol patches with medroxyprogesterone acetate for female subjects.…”
Section: Study Populationmentioning
confidence: 99%
See 2 more Smart Citations
“…Causes of GHD include congenital lack of somatotrophs, due to pituitary aplasia or hypoplasia, or loss/destruction of somatotrophs resulting from hypothalamic-pituitary trauma, tumor, surgery, or radiation. Children with hypopituitarism, with multiple pituitary hormone deficiencies (MPHD), have generally been found to have structural hypothalamic/pituitary abnormalities evident on magnetic resonance imaging (MRI) (1,2,3) or identifiable genetic causes (3,4,5,6,7). However, many childhood cases of GHD are still diagnosed as idiopathic, where the true cause remains unknown, especially if the diagnostic workup does not extend beyond functional testing of GH secretion.…”
Section: Introductionmentioning
confidence: 99%